SG11201407446TA - Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy - Google Patents

Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Info

Publication number
SG11201407446TA
SG11201407446TA SG11201407446TA SG11201407446TA SG11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA SG 11201407446T A SG11201407446T A SG 11201407446TA
Authority
SG
Singapore
Prior art keywords
immunotherapy
peptides
peptide
combination
hydrochloride salt
Prior art date
Application number
SG11201407446TA
Other languages
English (en)
Inventor
Paul Laidler
Imre Farkas
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of SG11201407446TA publication Critical patent/SG11201407446TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201407446TA 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy SG11201407446TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208293A GB201208293D0 (en) 2012-05-11 2012-05-11 Hydrochlorice salt of peptide
PCT/GB2013/051201 WO2013167897A1 (en) 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Publications (1)

Publication Number Publication Date
SG11201407446TA true SG11201407446TA (en) 2015-03-30

Family

ID=46396890

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407446TA SG11201407446TA (en) 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Country Status (17)

Country Link
US (1) US9657061B2 (enrdf_load_html_response)
EP (1) EP2847209B8 (enrdf_load_html_response)
JP (1) JP5982562B2 (enrdf_load_html_response)
KR (1) KR20150014955A (enrdf_load_html_response)
CN (1) CN104428311B (enrdf_load_html_response)
AU (1) AU2013257784A1 (enrdf_load_html_response)
BR (1) BR112014028130A2 (enrdf_load_html_response)
CA (1) CA2873120A1 (enrdf_load_html_response)
EA (1) EA201492068A1 (enrdf_load_html_response)
GB (2) GB201208293D0 (enrdf_load_html_response)
HK (1) HK1201850A1 (enrdf_load_html_response)
IL (1) IL235388A (enrdf_load_html_response)
IN (1) IN2014DN09367A (enrdf_load_html_response)
MX (1) MX2014013394A (enrdf_load_html_response)
SG (1) SG11201407446TA (enrdf_load_html_response)
WO (1) WO2013167897A1 (enrdf_load_html_response)
ZA (1) ZA201408290B (enrdf_load_html_response)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
LT3626731T (lt) 2014-12-23 2022-02-10 Immatics Biotechnologies Gmbh Nauji peptidai ir peptidų deriniai, skirti naudoti imunoterapijai prieš hepatoceliulinę karcinomą (hck) ir kitų rūšių vėžį
GB201501017D0 (en) 2014-12-23 2015-03-04 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
HRP20230878T8 (hr) 2015-03-27 2024-02-16 Immatics Biotechnologies Gmbh Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raznih karcinoma (seq id 25 - mrax5-003)
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
EP4021920A4 (en) * 2019-08-26 2023-08-16 Auro Peptides LTD IMPROVED PROCESS FOR THE PREPARATION OF ETELCALKETIDE HYDROCHLORIDE
TWI792442B (zh) * 2021-07-23 2023-02-11 建誼生技股份有限公司 依特卡肽鹽酸鹽之製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316632T3 (es) * 2001-12-05 2009-04-16 Circassia Limited Metodos y sistemas inmunoterapeuticos.
KR101728868B1 (ko) 2006-01-18 2017-05-02 포시 파마슈티컬스 컴퍼니 리미티드 안정성이 강화된 약학 조성물
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CN101820907B (zh) * 2007-08-15 2013-05-01 切尔卡西亚有限公司 针对过敏原去敏化的肽
GB2455108A (en) * 2007-11-28 2009-06-03 Circassia Ltd T-Cell dependent method for detecting non-allergic or intrinsic disorders
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
KR101943429B1 (ko) * 2010-03-31 2019-01-29 스타빌리테크 리미티드 바이러스 입자, 폴리펩타이드 또는 생물학적 물질의 안정화를 위한 부형제

Also Published As

Publication number Publication date
CN104428311A (zh) 2015-03-18
GB201208293D0 (en) 2012-06-20
HK1201850A1 (en) 2015-09-11
GB2517354A (en) 2015-02-18
EP2847209A1 (en) 2015-03-18
EP2847209B1 (en) 2020-08-05
KR20150014955A (ko) 2015-02-09
WO2013167897A1 (en) 2013-11-14
CA2873120A1 (en) 2013-11-14
US20150110820A1 (en) 2015-04-23
IN2014DN09367A (enrdf_load_html_response) 2015-07-17
CN104428311B (zh) 2019-11-01
GB201421491D0 (en) 2015-01-14
EP2847209B8 (en) 2020-10-07
JP5982562B2 (ja) 2016-08-31
US9657061B2 (en) 2017-05-23
BR112014028130A2 (pt) 2017-08-15
EA201492068A1 (ru) 2015-03-31
MX2014013394A (es) 2015-02-04
JP2015517484A (ja) 2015-06-22
ZA201408290B (en) 2016-01-27
AU2013257784A1 (en) 2014-11-20
IL235388A (en) 2016-06-30

Similar Documents

Publication Publication Date Title
IL260045B (en) Polypeptide structures and their uses
IL230918A0 (en) Modified proteins and peptides
ZA201308251B (en) Amino acid sequence presenting fusion polypeptide and its use
ZA201404962B (en) Modified mini-hepcidin peptides and methods of using thereof
ZA201408290B (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
EP2928562A4 (en) PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE
IL279676A (en) Recombinant proteins and therapeutic uses
EP2788013A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
EP2720704A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
SG184289A1 (en) Novel peptides and methods for their preparation and use
EP2874642A4 (en) Anti-inflammatory proteins and peptides, and methods for their preparation and use
IL222027A (en) Peptides and their use
ZA201400562B (en) Axmi205 variant proteins and methods for their use
SG11201500111VA (en) Peptides and uses thereof
IL233481A0 (en) Peptides and methods of using them
IL237135A0 (en) Peptide library and their uses
PL2668205T3 (pl) Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie
EP2825548A4 (en) MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
EP2762149A4 (en) PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF
EP2680879A4 (en) PEPTID LINKERS FOR POLYPEPTIDE COMPOSITIONS AND APPLICATION METHOD THEREFOR
EP2836227A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
EP2771689A4 (en) PEPTIDES USP2A AND ANTIBODIES
GB201121236D0 (en) Proteins and peptides
GB201121233D0 (en) Modified proteins and peptides
GB201121226D0 (en) Modified proteins and peptides